Welcome to the 2026 EASL Liver Cancer Summit in Edinburgh, the leading event for liver cancer research and clinical practice.
Rapid advancements in hepatocellular carcinoma and cholangiocarcinoma are transforming treatment strategies, with immunotherapy, new systemic therapies, and AI-driven diagnostics reshaping the field. This summit offers a unique opportunity to engage with experts across disciplines, explore the latest in basic, translational, and clinical research, and address evolving standards in personalised care.
Join the global liver cancer community in Edinburgh from 22–24 January 2026.
Learning objectives
- Review the latest advances in the characterization, diagnosis, and clinical management of patients with primary liver cancer.
- Understand the molecular pathogenesis of liver cancer and explore emerging targeted and immune-based therapies.
- Examine the current clinical practice guidelines for the management of advanced hepatocellular carcinoma, including new immune combination therapies.
- Analyze the role of surgical and loco-regional therapies within a multidisciplinary treatment approach.
- Appreciate the complexity of personalized treatment decisions, taking into account patient needs, expectations, and healthcare resource constraints.
- Explore current challenges and future developments in clinical and basic science, and their impact on treatment strategies and patient outcomes.
Top reasons to attend
The EASL Liver Cancer Summit will cover current knowledge on basic and clinical science exclusively dedicated to primary liver cancer.
In a friendly and dynamic environment, the LCS brings together not only the most influential leaders in the field of primary liver cancer, but also all other specialists around the world who share a common goal and passion.
We will learn all about the most recent results in clinical trials and the most interesting ongoing research in basic and clinical science.
Going back home after the LCS means having new standards, new ideas, new perspectives to improve patients’ experience and outcomes and possibly to design innovative trials to find the answer to unsolved questions and unmet needs.
Add event to calendar
